Results 171 to 180 of about 80,621 (311)

A single-cell transcriptomic landscape characterizes the endocrine system aging in the mouse. [PDF]

open access: yesProtein Cell
Wei R   +11 more
europepmc   +1 more source

Associations of war‐related exposures and early life adversity with late‐life cognition

open access: yesAlzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract INTRODUCTION We examined associations of early life adversity (ELA) and war exposures with late‐life cognition of participants in the Vietnamese Insights into Cognitive Aging Program (VIP). METHODS Participants completed psychosocial and neuropsychological assessments, the latter including measures of global cognition, executive function ...
Oanh L. Meyer   +13 more
wiley   +1 more source

Adrenal lipoma formation via PI(3,4,5)P<sub>3</sub>/AKT-dependent transdifferentiation of adrenocortical cells into adipocytes. [PDF]

open access: yesProc Natl Acad Sci U S A
Yanai S   +15 more
europepmc   +1 more source

Thyroid function tests in endemic goitre [PDF]

open access: yes, 1967
Alberts, H.   +4 more
core   +1 more source

Wake‐promoting neuromodulators in Alzheimer's disease: Implications for sleep and brain clearance

open access: yesAlzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract Neuromodulatory subcortical systems (NSS) regulate arousal, cognition, and sleep–wake transitions through widespread influence on cortical and subcortical networks. Increasing evidence links dysfunction of these systems to the pathogenesis of Alzheimer's disease (AD). Degeneration and dysregulation of NSS occurs during the preclinical phase of
Taylor J. Pedersen   +7 more
wiley   +1 more source

Morphological and Transcriptomic Analyses of the Adrenal Gland in <i>Acomys cahirinus</i>: A Novel Model for Murine Adrenal Physiology. [PDF]

open access: yesCells
Bilyalova A   +14 more
europepmc   +1 more source

Pharmacokinetics, pharmacodynamics and safety of vutiglabridin after multiple oral administrations in healthy female and obese subjects

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 3, Page 860-868, March 2026.
Aims Vutiglabridin (HSG4112) is a novel drug under clinical development for antiobesity treatment. This study aimed to evaluate the pharmacokinetics (PKs) and safety of vutiglabridin after multiple oral administrations in healthy Korean female and obese subjects and explore short‐term pharmacodynamic (PD) responses.
Sooyoun Lee   +5 more
wiley   +1 more source

Endocrine dysfunctions as complications and comorbidities of juvenile idiopathic arthritis. [PDF]

open access: yesReumatologia
Kamińska M   +5 more
europepmc   +1 more source

On the adrenal subcellular distibution of 3H-ACTH [PDF]

open access: yes, 1968
Margoulies, M.   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy